Data Characteristics for This Category
Academic promotion clinical trial pre-screening data primarily originates from global clinical trial registries (e.g., ClinicalTrials.gov, WHO ICTRP), as well as clinical research reports, Investigator's Brochures (IBs) from biopharmaceutical companies, and real-world evidence (RWE) data from post-market drug studies. Update frequencies vary; registry information typically updates quarterly or monthly, while reports and brochures are released at specific trial milestones or due to regulatory requirements. Document structures often include PDF-formatted clinical trial protocols with structured headings, tables (e.g., inclusion/exclusion criteria, endpoints), charts, and unstructured text descriptions. Key fields include trial name, disease area (e.g., ICD-10 codes), drug name, research institution, study phase, primary and secondary endpoints, subject recruitment status, inclusion/exclusion criteria, and precise dosage information with units (e.g., dose, frequency).
Constraints Imposed by These Characteristics on Knowledge Base Retrieval and Recall
The PDF format and mixed structure of clinical trial protocols challenge document parsing. This requires intelligent recognition of structured elements and unstructured text to prevent information loss or incorrect segmentation. Data source diversity means the knowledge base must integrate information with varying formats and update cycles, demanding high data freshness. The specialized nature of fields (e.g., ICD-10 codes) and precision of units (e.g., mg/kg) require accurate recall results, avoiding misjudgments due to semantic ambiguity. For example, during similarity matching, relying solely on word vectors might not distinguish different dosage units or trial phases. Furthermore, critical information (e.g., specific gene mutation types) can be deeply embedded in lengthy texts, demanding higher precision and contextual understanding from recall. To ensure pre-screening accuracy, the knowledge base must identify and link synonymous entities scattered across different documents, such as trade names and generic names for various drugs.
Configuration Settings
| Configuration Item | Suggested Value | Rationale |
|---|---|---|
Chunk size (Segment Length) | 800–1200 characters | Clinical trial documents have long paragraphs. Shorter segments lose context, while longer ones dilute key information. This range helps retain complete semantic blocks. |
Segment Overlap | 150 characters | Ensures critical information, especially list-like content such as inclusion/exclusion criteria, is not truncated across segments. |
Recall count (Recall Count) | Top 8 entries (Top 8) | Needs to cover enough potentially relevant trials while avoiding interference from irrelevant information. 8 is an empirical balance of efficiency and recall rate. |
Similarity threshold (Similarity Threshold) | 0.78–0.82 | Academic promotion demands high accuracy. This range effectively filters low-relevance results while retaining potential matches. |
Rerank result count (Rerank Return Count) | Top 5 entries (Top 5) | Further refines the recalled results, focusing on the most relevant trials and reducing the model's processing burden. |
PARSE_FILE_TIMEOUT_SECONDS | 600 seconds (600 seconds) | Clinical trial protocol PDFs can be large and complex. Sufficient parsing time is needed to prevent file processing failures due to timeouts. |
Three Common Mistakes
- Symptom: Knowledge base retrieval results contain a large amount of irrelevant clinical trial information, or critical information is missing. Reason:
Chunk size(Segment Length) is set too short, leading to fragmented key context, orSimilarity threshold(Similarity Threshold) is too low, failing to effectively filter noise. - Symptom: After uploading a large clinical trial protocol PDF, the system is unresponsive for a long time or reports
JSON parsing error. Reason: ThePARSE_FILE_TIMEOUT_SECONDSparameter is insufficient for parsing complex or large documents, leading to a parsing timeout. - Symptom: When searching for clinical trials for a specific disease (e.g.,
non-small cell lung cancer), results are mixed with trials for other lung diseases. Reason: The knowledge base did not fully utilize professional codes likeICD-10for entity recognition and semantic enhancement during construction, leading to an inability to distinguish subtle disease differences during word vector matching.
How to Verify Correct Configuration
- Select representative disease areas and drugs. Build a test set containing known matching and non-matching trials. Execute retrieval and cross-check the accuracy and recall rate of the results.
- Upload and index clinical trial protocol PDF files of varying lengths and complexities. Observe if file processing is successful and check if the indexed text content is complete and structurally correct.
- For queries containing critical numerical information (e.g., dose
10 mg/kg) and specialized codes (e.g.,EGFR mutation), check if the recall results accurately identify and present these key fields and units. Evaluate the contextual relevance of the recall results. - Monitor system logs for error messages due to file parsing timeouts or memory overflows. This helps determine if
PARSE_FILE_TIMEOUT_SECONDSand other resource configurations are appropriate.
The values provided are common starting points and should be measured against the reader's own samples.
Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.